How to Select the Right ADME Partner for your Drug Discovery Program.

As drug discovery programs become increasingly diverse and demanding, selecting the right ADME and DMPK partner is more important than ever.

Modalities are expanding, timelines are tightening, and the margin for error is smaller. Against this backdrop, it’s important to remember that selecting the right ADME partner isn’t just a procurement decision, it’s a scientific one.

While technical capabilities are essential, the most effective ADME partnerships go beyond routine testing. Scientific expertise, bioanalytical capabilities, translational modeling, and collaborative approach all have a significant impact on program success.

Here’s what to look for in the partner that will help you turn data into confident decisions:

Integrated drug discovery support

The true value of ADME data comes from being interpreted alongside insights from medicinal chemistry, biology, pharmacology, and translational science. A compound that looks metabolically unstable in isolation might be perfectly viable once you factor in target engagement, exposure requirements, and dose projections.

Likewise, promising in vitro potency can be misleading if permeability or other ADME liabilities are not connected to the SAR (structure-activity relationship) and addressed during optimization.

Program context matters as much as assay accuracy. A partner who understands the therapeutic area and modality is better placed to spot which data points matter and could change a decision.

At Concept Life Sciences, we work collaboratively across disciplines to translate findings into actionable recommendations. Our experience across a wide range of therapeutic areas, including oncology, metabolic disorders, inflammation and neuroscience, enable us to understand the broader context of a program and design studies that answer the most relevant questions.

Modality-specific expertise

Different therapeutic modalities present different ADME challenges. Small molecules, peptides, oligonucleotides, antibody-drug conjugates, PROTACS and other emerging therapeutic modalities each bring their own developability considerations and require tailored study strategies.

Small molecules might be the best-understood modality, but even so, standard microsomal stability assays can miss non-CYP-mediated clearance routes, and permeability results don't always predict what will happen in a different biological system.

Peptide ADME needs to consider protease degradation and oral bioavailability, and PROTACs often don’t follow classical dose-response relationships. If your ADME partner doesn’t have the right expertise in these modalities, then they won’t surface the risks that matter for your program.

Our team has experience across a range of emerging modalities and works closely with clients to understand the specific requirements of their program to recommend the most appropriate assay cascade at each stage of the drug discovery.

PK and bioanalytical expertise

ADME, bioanalysis, and pharmacokinetics are often treated as separate workstreams, sometimes even run through different providers. In practice, that separation can cause serious risks to your program: data doesn't always align cleanly, timelines stack up, and nuance gets lost in handoffs between teams who aren't looking at the whole picture.

Bringing ADME, bioanalytical, and pharmacokinetic expertise under one roof provides a more complete understanding of compound behavior while simplifying project delivery.

Our Discovery Bioanalysis team develops tailored analytical methods, including customized LC-MS/MS assays, to generate robust, sensitive data that support pharmacokinetic characterization and compound progression.

Translational and modeling expertise

A key challenge in drug discovery is translating preclinical findings into clinical success, and decisions made on incomplete PK/PD understanding are a common source of costly late-stage failure.

Our DMPK scientists integrate ADME data with pharmacokinetic and pharmacodynamic (PK/PD) modeling, helping to predict exposure, support dose selection, and improve confidence in progression decisions.

By combining experimental data with translational insights, we help clients make better-informed decisions throughout development.

Flexibility and scientific collaboration

Drug discovery programs evolve rapidly, and new challenges often emerge as data is generated. A rigid service model with fixed scope and limited access to the scientists generating data, struggles to keep pace with that reality.

We pride ourselves on being more than a service provider. We work as an extension of your team, offering flexibility, expert guidance, and direct access to experienced scientists throughout a project.

This collaborative approach enables us to adapt study strategies as programs develop and helps ensure that data are translated into meaningful next steps.

Quality data, rapid turnaround, and cost efficiency

Reliable data might be fundamental to successful decision-making; but speed and budget considerations are equally important in today's drug discovery environment where timelines and compressed and budgets scrutinized. Slow data delays decisions; rushed data undermines confidence in them; and either can end up costing more than it saves.

We combine scientific rigor with efficient workflows and clear communication and deliver high-quality data within timelines that support fast-moving discovery programs. Our goal is to help clients generate the insights they need as efficiently as possible, maximizing the value of their investment while reducing development risk.

Building long-term partnerships

Ultimately, choosing an ADME partner is about more than access to assays. It is about finding a trusted scientific partner that can help move compounds efficiently from discovery to the clinic.

At Concept Life Science’s, we provide integrated ADME, bioanalytical, and DMPK capabilities across a broad range of therapeutic modalities and disease areas, supporting clients as they advance programs from discovery towards the clinic.

Ready to see what Concept Life Sciences can offer for your ADME program?

Contact us today to speak to our team.